Cho Kwang Pain
Chokwang Paint Ltd. manufactures and sells paints and chemicals in South Korea and internationally. It offers architectural, floor and waterproofing, heavy duty, industrial, wood, plastic, and UV curing paints; powder coatings, adhesives, electronic materials, and car maintenance products; and energy saving products. The company was founded in 1947 and is headquartered in Busan, South Korea.
Cho Kwang Pain (004910) - Net Assets
Latest net assets as of September 2025: ₩216.18 Billion KRW
Based on the latest financial reports, Cho Kwang Pain (004910) has net assets worth ₩216.18 Billion KRW as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩435.37 Billion) and total liabilities (₩219.19 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩216.18 Billion |
| % of Total Assets | 49.65% |
| Annual Growth Rate | 3.87% |
| 5-Year Change | -6.07% |
| 10-Year Change | 14.48% |
| Growth Volatility | 7.99 |
Cho Kwang Pain - Net Assets Trend (2011–2024)
This chart illustrates how Cho Kwang Pain's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Cho Kwang Pain (2011–2024)
The table below shows the annual net assets of Cho Kwang Pain from 2011 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩190.12 Billion | +8.46% |
| 2023-12-31 | ₩175.30 Billion | +3.28% |
| 2022-12-31 | ₩169.73 Billion | -2.74% |
| 2021-12-31 | ₩174.51 Billion | -13.79% |
| 2020-12-31 | ₩202.42 Billion | +17.19% |
| 2019-12-31 | ₩172.73 Billion | -0.74% |
| 2018-12-31 | ₩174.03 Billion | -4.29% |
| 2017-12-31 | ₩181.83 Billion | -0.78% |
| 2016-12-31 | ₩183.26 Billion | +10.35% |
| 2015-12-31 | ₩166.08 Billion | +10.53% |
| 2014-12-31 | ₩150.26 Billion | +9.95% |
| 2013-12-31 | ₩136.66 Billion | +7.52% |
| 2012-12-31 | ₩127.10 Billion | +9.47% |
| 2011-12-31 | ₩116.11 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Cho Kwang Pain's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1420.5% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩151.16 Billion | 79.69% |
| Other Components | ₩38.53 Billion | 20.31% |
| Total Equity | ₩189.69 Billion | 100.00% |
Cho Kwang Pain Competitors by Market Cap
The table below lists competitors of Cho Kwang Pain ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Impedimed Ltd
AU:IPD
|
$17.91 Million |
|
Aztec Minerals Corp
OTCQB:AZZTF
|
$17.91 Million |
|
ANKM
OTCQB:ANKM
|
$17.91 Million |
|
PINE Technology Holdings Limited
F:PNY
|
$17.92 Million |
|
STRAN + CO.INC. DL -0001
F:S9H
|
$17.90 Million |
|
Critical Holdings Berhad
KLSE:0291
|
$17.90 Million |
|
Era Media Sejahtera
JK:DOOH
|
$17.89 Million |
|
Canterra Minerals Corporation
OTCQB:CTMCF
|
$17.89 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Cho Kwang Pain's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 174,993,070,040 to 189,694,923,280, a change of 14,701,853,240 (8.4%).
- Net income of 15,982,987,690 contributed positively to equity growth.
- Dividend payments of 2,032,292,600 reduced retained earnings.
- New share issuances of 6,000,010,190 increased equity.
- Other factors decreased equity by 5,248,852,040.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩15.98 Billion | +8.43% |
| Dividends Paid | ₩2.03 Billion | -1.07% |
| Share Issuances | ₩6.00 Billion | +3.16% |
| Other Changes | ₩-5.25 Billion | -2.77% |
| Total Change | ₩- | 8.40% |
Book Value vs Market Value Analysis
This analysis compares Cho Kwang Pain's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.26x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | ₩17316.86 | ₩4855.00 | x |
| 2018-12-31 | ₩16574.03 | ₩4855.00 | x |
| 2019-12-31 | ₩16450.92 | ₩4855.00 | x |
| 2020-12-31 | ₩20015.79 | ₩4855.00 | x |
| 2021-12-31 | ₩16681.58 | ₩4855.00 | x |
| 2022-12-31 | ₩16694.81 | ₩4855.00 | x |
| 2023-12-31 | ₩17221.25 | ₩4855.00 | x |
| 2024-12-31 | ₩18534.75 | ₩4855.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Cho Kwang Pain utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 8.43%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 6.44%
- • Asset Turnover: 0.63x
- • Equity Multiplier: 2.07x
- Recent ROE (8.43%) is above the historical average (3.60%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2011 | 5.19% | 3.62% | 0.83x | 1.74x | ₩-5.58 Billion |
| 2012 | 10.03% | 7.37% | 0.79x | 1.71x | ₩41.88 Million |
| 2013 | 8.59% | 6.36% | 0.82x | 1.66x | ₩-1.92 Billion |
| 2014 | 11.15% | 8.65% | 0.80x | 1.61x | ₩1.73 Billion |
| 2015 | 11.62% | 10.18% | 0.79x | 1.45x | ₩2.69 Billion |
| 2016 | 9.93% | 9.65% | 0.75x | 1.38x | ₩-123.41 Million |
| 2017 | 2.36% | 2.14% | 0.76x | 1.46x | ₩-13.88 Billion |
| 2018 | -2.24% | -1.86% | 0.69x | 1.74x | ₩-21.30 Billion |
| 2019 | -1.34% | -1.14% | 0.65x | 1.81x | ₩-19.59 Billion |
| 2020 | 2.21% | 2.22% | 0.58x | 1.73x | ₩-15.78 Billion |
| 2021 | -13.98% | -10.23% | 0.69x | 1.99x | ₩-41.84 Billion |
| 2022 | -4.27% | -2.78% | 0.67x | 2.28x | ₩-24.22 Billion |
| 2023 | 2.72% | 1.88% | 0.66x | 2.19x | ₩-12.74 Billion |
| 2024 | 8.43% | 6.44% | 0.63x | 2.07x | ₩-2.99 Billion |
Industry Comparison
This section compares Cho Kwang Pain's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $791,185,473,650
- Average return on equity (ROE) among peers: 6.02%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Cho Kwang Pain (004910) | ₩216.18 Billion | 5.19% | 1.01x | $17.90 Million |
| DL Holdings CO. LTD. (000210) | $4.53 Trillion | 19.10% | 0.84x | $381.57 Million |
| Norooholdings (000320) | $402.45 Billion | 6.30% | 1.12x | $45.80 Million |
| Noroo Holdings Co Ltd (000325) | $583.54 Billion | 0.27% | 0.81x | $60.77 Million |
| Samhwa Paint (000390) | $299.72 Billion | 1.87% | 0.96x | $86.24 Million |
| Kangnam Jevisco Co Ltd (000860) | $366.15 Billion | 10.97% | 0.26x | $58.42 Million |
| Paik Kwang Ind (001340) | $204.57 Billion | 3.85% | 1.06x | $113.44 Million |
| Bo Lak (002760) | $43.76 Billion | 2.53% | 0.22x | $30.02 Million |
| Songwon Industrial (004430) | $543.25 Billion | 13.30% | 1.05x | $79.87 Million |
| Cosmoam&T (005070) | $147.00 Billion | -3.99% | 0.78x | $305.37 Million |